INO

INO

USD

Inovio Pharmaceuticals Inc. Common Stock

$2.430+0.000 (0.000%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$2.430

High

$2.575

Low

$2.410

Volume

1.91M

Company Fundamentals

Market Cap

129.1M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

1.60M

Exchange

NCM

Currency

USD

52-Week Range

Low $1.3Current $2.430High $5.8

Related News

PR Newswire

INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

View more
INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults
PR Newswire

INOVIO Reports Inducement Grant Under Inducement Plan

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

View more
INOVIO Reports Inducement Grant Under Inducement Plan
PR Newswire

INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

View more
INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025
PR Newswire

INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

View more
INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference
PR Newswire

Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

View more
Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine